Passer au contenu principal

Subventions financées

Filtrer par:
Effacer les filtres
Filtrer par:

815 résultats trouvés

Biomarkers for Crossing the Translational Divide in Acute Spinal Cord Injury

Each year, over 1,500 Canadians sustain an acute spinal cord injury (SCI), and join close to 40,000 across our nation living with one of the most physically and psychologically devastating of injuries.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Blessures
Province
Colombie-Britannique
DATE DE DÉBUT
2015

Adolescent Mental Health

Most mental disorders begin in adolescence; however, there are many gaps in our understanding of youth mental health.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Santé mentale
Province
Alberta
DATE DE DÉBUT
2015

Targeting the Synaptic Pathway in Neurodevelopmental and Psychiatric Disorders

Autism spectrum disorders are neurodevelopmental disorders characterized by deficits in social interaction, poor communication, and restricted, stereotyped patterns of behavior.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Multiple
Province
Colombie-Britannique
DATE DE DÉBUT
2015

Understanding stress to improve mental health

Recent estimates indicate that 1 in 5 Canadians are affected annually by mood, anxiety and other mental illnesses.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Santé mentale
Province
Alberta
DATE DE DÉBUT
2015

Human MiniPromoters for Restricted Expression of Ocular Gene Therapy

The purpose of this project is to develop promoters. Promoters are pieces of DNA, which act as switches to turn genes on and off.


TYPE DE SUBVENTION
Subventions de la plate-forme
Domaine de recherche
Système sensoriel
Concours
CQDM - Brain Canada - Pleins feux sur le cerveau
Province
Colombie-Britannique
DATE DE DÉBUT
2015

Oncolytic rhabdovirus immunotherapy for brain cancer

Dr David Stojdl’s lab has custom‑built an oncolytic virus biotherapy specifically for the treatment of the devastating brain cancer, glioblastoma multiforme (GBM).


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Le cancer
Province
Ontario
DATE DE DÉBUT
2015

Targeting the telomere maintenance pathway for cancer diagnostics and therapeutics.

Cancer can exhibit relentless growth and relapse because of the enhanced protection of its chromosome ends.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Le cancer
Province
Ontario
DATE DE DÉBUT
2015

Molecular heterogeneity drives the clinical behaviour of childhood medulloblastoma

Brain cancer is the most common type of solid cancer in children in Canada, and medulloblastoma is the most common malignant brain cancer of childhood.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Le cancer
Province
Ontario
DATE DE DÉBUT
2015

Targeting Amyloid Propagation in Alzheimer Disease: Structures, Immunology and Extracellular Vesicle Topology

A treatment or prevention of Alzheimer’s disease is a top priority for medical science.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Colombie-Britannique
DATE DE DÉBUT
2015

Locally produced brain insulin in memory and Alzheimer’s disease: A multi-disciplinary approach to a key question

One percent of Alzheimer’s disease is the early-onset type that runs in families.


TYPE DE SUBVENTION
Subventions d'équipe
Domaine de recherche
Neurodégénérescence
Province
Colombie-Britannique
DATE DE DÉBUT
2015